Amgen to Invest More Than $600 Million in New Science and Innovation Centre in California
Introduction:
Amgen has announced plans to invest over $600 million in a new, state-of-the-art Centre for Science and Innovation at its global headquarters in Thousand Oaks, California. The facility will bring together scientists, engineers, and researchers to enhance collaboration and accelerate the discovery of next-generation treatments for serious illnesses.
Features:
The building will include advanced automation and digital technologies, creating an environment designed to drive excellence in biotechnology and support the development of future medicines.
This new centre reflects Amgen’s continued investment in U.S. science and manufacturing.
Recent pro-growth tax policies have further enabled Amgen to invest domestically in cutting-edge science and production facilities.
The project builds on other major investments, including a $900 million expansion of Amgen’s manufacturing facility in Central Ohio and a $1 billion investment to build a second manufacturing plant in Holly Springs, North Carolina.
Together, these initiatives strengthen Amgen’s global network of sites and reinforce its leadership in biotechnology innovation.
Specifications:
| Name | Amgen |
| Budget | $600 million |
| Type | Construction |
